Newsroom

January:

Agile Sciences Receives $1.5M Phase II SBIR Grant - News release

July:

Agile Sciences Receives $1.5M Phase II STTR Grant - News release

 

April:

Agile Sciences announces issuance of two additional US patents - News release

August:

Agile Sciences adds two members to Company's Board of Directors - News release

 

February:

A fourth US Patent is issued on Agile Sciences' technology - News release

 

Agile Sciences receives $300,000 grant to evaluate technology for treating infective endocarditis - News release

 

January:

Agile Sciences receives grant from Bay Area Lyme Fund - News release

November:

Agile Sciences' co-founders named Entrepreneurs of the Year by NC State University - News release

 

October:

Agile Sciences' co-founder develops molecule with enhanced potency for restoring MRSA sensitivity to antibiotics - News release

 

Agile Sciences announces issuance of US Patent covering agricultural applications of Company's anti-biofilm compounds -
News release

 

July:

The National Science Foundation grants Agile Sciences a $150,000 Phase I SBIR award to develop Agile Sciences' technology for treating copper-resistant plant diseases - News release

 

May:

Agile Sciences receives a $257,000 Phase I NIH SBIR Award to evaluate the ability of Agile Sciences' compounds to enhance the efficacy of antiseptic products - News release

 

April:

Agile Sciences is awarded a $1M Phase II SBIR grant from the National Institutes of Health to advance Agile Sciences' treatment for dental caries - News release

 

February:

An Agile Sciences molecule is shown to enhance the efficacy of carbapenem antibiotics against a NDM-1-producing Klebsiella "superbug" - News release

October:

Agile Sciences and Calvert Research announce strategic collaboration - News release

 

September:

A $545,000 NIH Phase I SBIR SHIFT Grant is awarded to Agile Sciences to support human therapeutic development - News release

 

July:

Agile Sciences is awarded a NIH Phase I STTR Grant to evaluate technology in chronic wound models at the Center for Biofilm Engineering at Montana State University - News release

 

March:

Agile Sciences' collaboration with scientists at NC State University results in the identification of Agilyte-modified polymers that resist bacterial colonization. This work was funded by a NSF STTR Grant and has been published in Chemical Communications

 

Filtration membrane expert Dr. Thomas Engelhardt joins Agile Sciences' Scientific Advisory Board - News release

 

Second US Patent is issued, expanding Agile Science's proprietary compound library - News release

 

Agile Sciences receives a grant from the Cystic Fibrosis Foundation - News release

 

Agile Sciences announces issuance of U.S. Patent for biofilm dispersing compounds - News release

 

January:

Agile is granted a $150,000 NSF Phase I Award to incorporate its proprietary anti-biofilm small molecules into medical devices - News release